Filing Details
- Accession Number:
- 0001179110-15-012678
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-26 17:51:32
- Reporting Period:
- 2015-08-21
- Filing Date:
- 2015-08-26
- Accepted Time:
- 2015-08-26 17:51:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190578 | C John Martin | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-08-21 | 133,213 | $0.00 | 4,081,279 | No | 5 | G | Direct | |
Common Stock | Disposition | 2015-08-24 | 133,213 | $0.00 | 3,948,066 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2015-08-24 | 133,213 | $0.00 | 133,213 | No | 4 | A | Indirect | by Trust |
Common Stock | Disposition | 2015-08-25 | 59,800 | $104.33 | 73,413 | No | 4 | S | Indirect | by Trust |
Common Stock | Disposition | 2015-08-25 | 56,613 | $105.68 | 16,800 | No | 4 | S | Indirect | by Trust |
Common Stock | Disposition | 2015-08-25 | 16,800 | $106.45 | 0 | No | 4 | S | Indirect | by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | G | Direct | |
No | 4 | A | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
Footnotes
- Shares gifted to charitable trust
- Sale prices reported for the transactions reported here range from $104.17 to $105.13. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $105.20 to $106.19. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $106.23 to $106.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.